Pedro J. Caraballo

According to our database1, Pedro J. Caraballo authored at least 21 papers between 2012 and 2018.

Collaborative distances:
  • Dijkstra number2 of five.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Other 

Links

On csauthors.net:

Bibliography

2018
Empowering genomic medicine by establishing critical sequencing result data flows: the eMERGE example.
JAMIA, 2018

2017
Providers' Response to Clinical Decision Support for QT Prolonging Drugs.
J. Medical Systems, 2017

Technical Challenges and Opportunities when Implementing Pharmacogenomics Decision Support Integrated in the Electronic Health Record.
Proceedings of the MEDINFO 2017: Precision Healthcare through Informatics, 2017

Estimating Disease Onset Time by Modeling Lab Result Trajectories via Bayes Networks.
Proceedings of the 2017 IEEE International Conference on Healthcare Informatics, 2017

Evolving Pharmacogenomics Test Results and the Burden on Clinical Decision Support Integrated in the Electronic Health Record.
Proceedings of the Summit on Clinical Research Informatics, 2017

Development & Implementation of a Clinical Decision Support Tool for Familial Hypercholesterolemia.
Proceedings of the AMIA 2017, 2017

2016
Implementing Pharmacogenomic Clinical Decision Support: Design and Prescriber Response in the eMERGE Network.
Proceedings of the AMIA 2016, 2016

Clinical Decision Support to Detect High Risk Patients with QTc Prolongation.
Proceedings of the AMIA 2016, 2016

2015
Extending Association Rule Summarization Techniques to Assess Risk of Diabetes Mellitus.
IEEE Trans. Knowl. Data Eng., 2015

Impact of clinical decision support preventing the use of QT-prolonging medications for patients at risk for torsade de pointes.
JAMIA, 2015


CDS, EHR and Pharmacogenomics to Estimate Warfarin Dosing.
Proceedings of the AMIA 2015, 2015

2014
Clinical Decision Support Integrated in the Electronic Medical Record to Reduce Overuse of Blood Product Transfusion in the Cardiac Surgery ICU.
Proceedings of the AMIA 2014, 2014

Point of Care Intake Tool and Clinical Decision Support to Achieve Meaningful Use.
Proceedings of the AMIA 2014, 2014

Divisive Hierarchical Clustering towards Identifying Clinically Significant Pre-Diabetes Subpopulations.
Proceedings of the AMIA 2014, 2014

Use of Enterprise Clinical Decision Support Infrastructure to Implement Pharmacogenomics at the Point of Care.
Proceedings of the AMIA 2014, 2014

2013
Survival Association Rule Mining Towards Type 2 Diabetes Risk Assessment.
Proceedings of the AMIA 2013, 2013

Quantifying the Effect of Statin Use in Pre-Diabetic Phenotypes Discovered Through Association Rule Mining.
Proceedings of the AMIA 2013, 2013

Clinical Decision Support Rule Performance Reporting: Helpful or Heartache?
Proceedings of the AMIA 2013, 2013

2012
Impact of data fragmentation across healthcare centers on the accuracy of a high-throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus.
JAMIA, 2012

Clinical Burden and Risk of Alert Fatigue Associated with Detection and Documentation of Prolonged QT Interval Using an Expert Rule System.
Proceedings of the AMIA 2012, 2012


  Loading...